Jeremy Green, Director, 10% Owner at FATE THERAPEUTICS INC (FATE), bought 5,685,290 shares at $6.00 ($32.2M) on 2023-04-14, disclosed to the SEC on 2023-04-17.
Open-market purchase of $32.2M FATE by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 167,205 | $0 | 0.0% |
| 2 | $5.84 | 5,492,385 | $32.1M | 99.5% |
| 3 | $6.00 | 25,700 | $154K | 0.5% |
| Total | $5.67 avg | 5,685,290 | $32.2M | 100% |
| Filing → |
| ADCT | BUY | 2024-12-13 | $419K | — | Filing → |
| STTK | BUY | 2024-12-06 | $333K | — | Filing → |
| STTK | SELL | 2024-12-06 | $333K | — | Filing → |